CAE Healthcare is collaborating with Area9 Lyceum to provide clinicians with an online COVID-19 Ventilator Reskilling course. With modules covering basics in respiratory physiology, mechanical ventilation and goals of COVID-19 care, the course is being provided free of charge during the month of April.

“Clinical providers across specialities are being called to hospitals to provide care for COVID-19 patients, and they are seeking practical training and knowledge,” said Rekha Ranganathan, President of CAE Healthcare. “With the Area9 Lyceum adaptive learning platform, we can efficiently train clinicians with varied levels of exposure to ventilator management to achieve the required competencies for effective care.”

“The need for COVID-19 education of health care providers is explosive. We have seen this manifested clearly the past three weeks where more than 65,000 laboratory professionals have been certified on the COVID-19 course developed by Area9 Lyceum and leading laboratory professionals,” said Dr. Ulrik Juul Christensen (MD), Executive Chairman of Area9 Lyceum. The courses are freely available at https://area9lyceum.com/use-cases/courses/.

Since its release in April, more than 1,325 clinicians around the world have registered for the COVID-19 Ventilator Reskilling Course.

Throughout April, CAE Healthcare is also offering complimentary webinars and its COVID-19 Simulated Clinical Experience (SCE) to help caregivers practice personal safety procedures and patient assessment. CAE Healthcare and UK-based iRIS Health Solutions have shared the COVID-19 SCE free of charge to the global iRIS community across 40 countries and translated it into 7 additional languages. iRIS is a healthcare training authoring and sharing platform with more than 6,000 user licenses worldwide.

CAE was selected by the Canadian government to design and manufacture 10,000 ventilators over three months to support the COVID-19 crisis. CAE Healthcare is also developing a Point of Care Ultrasound (POCUS) COVID-19 training suite of products, and a simulation-based Pathogens of High Consequence course for release in the coming weeks.